Novartis AG

Industry / private company


Location: Basel, Switzerland (CH) CH

ISNI: 0000000115159979

ROR: https://ror.org/02f9zrr09

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Treatment-Free Remission in Real-World Chronic Myeloid Leukemia Patients: Insights from German Hematology Practices (2022) Dengler J, Tesch H, Jentsch-Ullrich K, Gerhardt A, Schulte C, Lipke J, Loewe G, Kiani A Journal article Physician-reported Clinical Unmet Needs, Burden and Treatment Patterns of Paediatric Psoriasis Patients: A US and EU Real-world Evidence Study (2022) Seyger MM, Augustin M, Sticherling M, Bachhuber T, Fang J, Hetherington J, Lucas J, et al. Journal article Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2− Advanced Breast Cancer in the MONALEESA-3 Trial (2022) Jerusalem G, Delea TE, Martin M, De Laurentiis M, Nusch A, Beck JT, Chan A, et al. Journal article Patient-reported outcomes and burden of disease in paediatric patients with psoriasis: real-world data from the EU5 and USA (2022) Seyger M, Paller A, Sticherling M, Bachhuber T, Fang J, Hetherington J, Lucas J, et al. Conference contribution Pooled safety analysis from two phase III studies of secukinumab in paediatric patients with moderate-to-severe plaque psoriasis up to week 52 (2022) Sticherling M, Nikkels AF, Hamza AM, Kwong P, Ortmann CE, Papanastasiou P, Forrer P, Keefe D Conference contribution A randomized clinical trial on the short-term effects of 12-week sacubitril/valsartan vs. enalapril on peak oxygen consumption in patients with heart failure with reduced ejection fraction: results from the ACTIVITY-HF study (2021) Halle M, Schoebel C, Winzer EB, Bernhardt P, Mueller S, Sieder C, Lecker LSM Journal article Lu-177-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial (2021) Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, et al. Journal article Technical validation of real-world monitoring of gait: a multicentric observational study (2021) Mazza C, Alcock L, Aminian K, Becker C, Bertuletti S, Bonci T, Brown P, et al. Journal article Effects of behavioural exercise therapy on the effectiveness of multidisciplinary rehabilitation for chronic non-specific low back pain: a randomised controlled trial (2021) Semrau J, Hentschke C, Peters S, Pfeifer K Journal article Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis (2021) Pournara E, Kormaksson M, Nash P, Ritchlin CT, Kirkham BW, Ligozio G, Pricop L, et al. Journal article